Takeda Pharmaceutical Co. Ltd. and Metabolon Initiate Research Collaboration to Discover Novel Targets and Biomarkers
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., a diagnostics and services company offering the industry’s leading biochemical profiling technology announces that Metabolon and Takeda Pharmaceutical Company Limited (TSE: 4502), a global pharmaceutical company, have formed a multiyear research alliance that will focus on discovering therapeutic targets and biomarkers.